Copyright Reports & Markets. All rights reserved.

Global Microsphere Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Microsphere Drug
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Microsphere Drug by Type
    • 1.3.1 Overview: Global Microsphere Drug Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Microsphere Drug Consumption Value Market Share by Type in 2022
    • 1.3.3 Leuprolide Microspheres
    • 1.3.4 Risperidone Microspheres
    • 1.3.5 Octreotide Microspheres
    • 1.3.6 Triptorelin Microspheres
    • 1.3.7 other
  • 1.4 Global Microsphere Drug Market by Application
    • 1.4.1 Overview: Global Microsphere Drug Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Cancer
    • 1.4.3 Mental Illness
    • 1.4.4 Other
  • 1.5 Global Microsphere Drug Market Size & Forecast
  • 1.6 Global Microsphere Drug Market Size and Forecast by Region
    • 1.6.1 Global Microsphere Drug Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Microsphere Drug Market Size by Region, (2018-2029)
    • 1.6.3 North America Microsphere Drug Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Microsphere Drug Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Microsphere Drug Market Size and Prospect (2018-2029)
    • 1.6.6 South America Microsphere Drug Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Microsphere Drug Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Johnson & Johnson
    • 2.1.1 Johnson & Johnson Details
    • 2.1.2 Johnson & Johnson Major Business
    • 2.1.3 Johnson & Johnson Microsphere Drug Product and Solutions
    • 2.1.4 Johnson & Johnson Microsphere Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.2 Takeda
    • 2.2.1 Takeda Details
    • 2.2.2 Takeda Major Business
    • 2.2.3 Takeda Microsphere Drug Product and Solutions
    • 2.2.4 Takeda Microsphere Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Takeda Recent Developments and Future Plans
  • 2.3 Novartis
    • 2.3.1 Novartis Details
    • 2.3.2 Novartis Major Business
    • 2.3.3 Novartis Microsphere Drug Product and Solutions
    • 2.3.4 Novartis Microsphere Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Novartis Recent Developments and Future Plans
  • 2.4 Ipsen Biopharmaceuticals, Inc
    • 2.4.1 Ipsen Biopharmaceuticals, Inc Details
    • 2.4.2 Ipsen Biopharmaceuticals, Inc Major Business
    • 2.4.3 Ipsen Biopharmaceuticals, Inc Microsphere Drug Product and Solutions
    • 2.4.4 Ipsen Biopharmaceuticals, Inc Microsphere Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Ipsen Biopharmaceuticals, Inc Recent Developments and Future Plans
  • 2.5 Ferring Pharmaceuticals
    • 2.5.1 Ferring Pharmaceuticals Details
    • 2.5.2 Ferring Pharmaceuticals Major Business
    • 2.5.3 Ferring Pharmaceuticals Microsphere Drug Product and Solutions
    • 2.5.4 Ferring Pharmaceuticals Microsphere Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Ferring Pharmaceuticals Recent Developments and Future Plans
  • 2.6 AstraZeneca
    • 2.6.1 AstraZeneca Details
    • 2.6.2 AstraZeneca Major Business
    • 2.6.3 AstraZeneca Microsphere Drug Product and Solutions
    • 2.6.4 AstraZeneca Microsphere Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 AstraZeneca Recent Developments and Future Plans
  • 2.7 Pfizer
    • 2.7.1 Pfizer Details
    • 2.7.2 Pfizer Major Business
    • 2.7.3 Pfizer Microsphere Drug Product and Solutions
    • 2.7.4 Pfizer Microsphere Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Pfizer Recent Developments and Future Plans
  • 2.8 AbbVie
    • 2.8.1 AbbVie Details
    • 2.8.2 AbbVie Major Business
    • 2.8.3 AbbVie Microsphere Drug Product and Solutions
    • 2.8.4 AbbVie Microsphere Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 AbbVie Recent Developments and Future Plans
  • 2.9 Beijing Biote Pharmaceutical Co.,Ltd
    • 2.9.1 Beijing Biote Pharmaceutical Co.,Ltd Details
    • 2.9.2 Beijing Biote Pharmaceutical Co.,Ltd Major Business
    • 2.9.3 Beijing Biote Pharmaceutical Co.,Ltd Microsphere Drug Product and Solutions
    • 2.9.4 Beijing Biote Pharmaceutical Co.,Ltd Microsphere Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Beijing Biote Pharmaceutical Co.,Ltd Recent Developments and Future Plans
  • 2.10 Livzon Pharmaceutical Group
    • 2.10.1 Livzon Pharmaceutical Group Details
    • 2.10.2 Livzon Pharmaceutical Group Major Business
    • 2.10.3 Livzon Pharmaceutical Group Microsphere Drug Product and Solutions
    • 2.10.4 Livzon Pharmaceutical Group Microsphere Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Livzon Pharmaceutical Group Recent Developments and Future Plans
  • 2.11 Luye Pharma
    • 2.11.1 Luye Pharma Details
    • 2.11.2 Luye Pharma Major Business
    • 2.11.3 Luye Pharma Microsphere Drug Product and Solutions
    • 2.11.4 Luye Pharma Microsphere Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Luye Pharma Recent Developments and Future Plans
  • 2.12 Grand Pharmaceutical Group Limited
    • 2.12.1 Grand Pharmaceutical Group Limited Details
    • 2.12.2 Grand Pharmaceutical Group Limited Major Business
    • 2.12.3 Grand Pharmaceutical Group Limited Microsphere Drug Product and Solutions
    • 2.12.4 Grand Pharmaceutical Group Limited Microsphere Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Grand Pharmaceutical Group Limited Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Microsphere Drug Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Microsphere Drug by Company Revenue
    • 3.2.2 Top 3 Microsphere Drug Players Market Share in 2022
    • 3.2.3 Top 6 Microsphere Drug Players Market Share in 2022
  • 3.3 Microsphere Drug Market: Overall Company Footprint Analysis
    • 3.3.1 Microsphere Drug Market: Region Footprint
    • 3.3.2 Microsphere Drug Market: Company Product Type Footprint
    • 3.3.3 Microsphere Drug Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Microsphere Drug Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Microsphere Drug Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Microsphere Drug Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Microsphere Drug Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Microsphere Drug Consumption Value by Type (2018-2029)
  • 6.2 North America Microsphere Drug Consumption Value by Application (2018-2029)
  • 6.3 North America Microsphere Drug Market Size by Country
    • 6.3.1 North America Microsphere Drug Consumption Value by Country (2018-2029)
    • 6.3.2 United States Microsphere Drug Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Microsphere Drug Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Microsphere Drug Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Microsphere Drug Consumption Value by Type (2018-2029)
  • 7.2 Europe Microsphere Drug Consumption Value by Application (2018-2029)
  • 7.3 Europe Microsphere Drug Market Size by Country
    • 7.3.1 Europe Microsphere Drug Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Microsphere Drug Market Size and Forecast (2018-2029)
    • 7.3.3 France Microsphere Drug Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Microsphere Drug Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Microsphere Drug Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Microsphere Drug Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Microsphere Drug Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Microsphere Drug Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Microsphere Drug Market Size by Region
    • 8.3.1 Asia-Pacific Microsphere Drug Consumption Value by Region (2018-2029)
    • 8.3.2 China Microsphere Drug Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Microsphere Drug Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Microsphere Drug Market Size and Forecast (2018-2029)
    • 8.3.5 India Microsphere Drug Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Microsphere Drug Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Microsphere Drug Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Microsphere Drug Consumption Value by Type (2018-2029)
  • 9.2 South America Microsphere Drug Consumption Value by Application (2018-2029)
  • 9.3 South America Microsphere Drug Market Size by Country
    • 9.3.1 South America Microsphere Drug Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Microsphere Drug Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Microsphere Drug Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Microsphere Drug Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Microsphere Drug Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Microsphere Drug Market Size by Country
    • 10.3.1 Middle East & Africa Microsphere Drug Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Microsphere Drug Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Microsphere Drug Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Microsphere Drug Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Microsphere Drug Market Drivers
  • 11.2 Microsphere Drug Market Restraints
  • 11.3 Microsphere Drug Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Microsphere Drug Industry Chain
  • 12.2 Microsphere Drug Upstream Analysis
  • 12.3 Microsphere Drug Midstream Analysis
  • 12.4 Microsphere Drug Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Microsphere Drug market size was valued at USD 9054.8 million in 2022 and is forecast to a readjusted size of USD 12010 million by 2029 with a CAGR of 4.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    Microsphere drug refers to a drug delivery system that uses micron-scale spherical particles as drug carriers, and wraps and encapsulates drug substances inside or on the surface of drug microspheres. By controlling the release rate and directional delivery of drug microspheres, this drug delivery system can achieve sustained drug release, reduce drug dose, improve drug stability, and regulate drug distribution and efficacy in vivo.
    This report is a detailed and comprehensive analysis for global Microsphere Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Microsphere Drug market size and forecasts, in consumption value ($ Million), 2018-2029
    Global Microsphere Drug market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
    Global Microsphere Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
    Global Microsphere Drug market shares of main players, in revenue ($ Million), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Microsphere Drug
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Microsphere Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, Takeda, Novartis, Ipsen Biopharmaceuticals, Inc and Ferring Pharmaceuticals, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market segmentation
    Microsphere Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Leuprolide Microspheres
    Risperidone Microspheres
    Octreotide Microspheres
    Triptorelin Microspheres
    other
    Market segment by Application
    Cancer
    Mental Illness
    Other
    Market segment by players, this report covers
    Johnson & Johnson
    Takeda
    Novartis
    Ipsen Biopharmaceuticals, Inc
    Ferring Pharmaceuticals
    AstraZeneca
    Pfizer
    AbbVie
    Beijing Biote Pharmaceutical Co.,Ltd
    Livzon Pharmaceutical Group
    Luye Pharma
    Grand Pharmaceutical Group Limited
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Microsphere Drug product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Microsphere Drug, with revenue, gross margin and global market share of Microsphere Drug from 2018 to 2023.
    Chapter 3, the Microsphere Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Microsphere Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
    Chapter 12, the key raw materials and key suppliers, and industry chain of Microsphere Drug.
    Chapter 13, to describe Microsphere Drug research findings and conclusion.

    Buy now